87793-001

Manufacturer
Yiwu Blackeye Import and Export Co Ltd.
Effective date
2026-06-17
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
monthly-update
Hydrated at
2026-07-17 21:34:33

Label at a glance#

ProductYABERCHA HAIR GROWTH SERUM
Active ingredientMINOXIDIL
Label structure12 sections

Dosage and administration

Apply once a day using a dropper, 1 milliliter each time, directly to the area of the scalp where hair loss occurs. Using more or more often will not improve results. Continued use is necessary to increase and keep your hair regrowth, orhair loss will begin again.

Storage and handling

Before use, read all information on carton. Keep the carton. It contains important information. Store at 20-25°C(68-77°F). Keep tightly closed.

Label contents#

Full prescribing information#

Active Ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Minoxdli 5% w/w

Purpose

OTC - PURPOSE SECTION

Hair regrowh teotnent

Use

INDICATIONS & USAGE SECTION

Use to regrow hair on the scalp

Warnings

WARNINGS SECTION

Warning:For external use only.

Do not use

OTC - DO NOT USE SECTION

1. You have no family history of hair loss.
2. your hair loss is sudden and/or patchy.
3. you do not know the reason for your hair loss.
4. you are under 18 years of age. Do not use on babies and children.
5. your scalp is red, inflamed, infected, irritated or painfu.
6. you use other medicines on the scalp.
7. You are using other medications on your scalp.

OTC - WHEN USING SECTION

1. do not apply on other parts of the body
2. avoid contact with the eyes. In case of accidental contact, ninse eyeswith large amounts of cool tap water.
3. some people have experienced changes in hair color and/or exture
4. it takes time to regrow hair. Results may occur at 4 months withcontinuous usage.
5. the amount of hair regrowth is different for each person. This productwill not work tor everyone.

OTC - STOP USE SECTION

1. chest pain, rapid heartbeat, faintness, or dizziness occurs
2. sudden, unexplained weight gain occurs
3. your hands or feet swell
4. scalp irritation or redness occurs
5. unwanted facial hair growth occurs
6. you do not see hair regrowth in 4 months

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Directions

DOSAGE & ADMINISTRATION SECTION

Apply once a day using a dropper, 1 milliliter each time, directly to the
area of the scalp where hair loss occurs.
Using more or more often will not improve results.
Continued use is necessary to increase and keep your hair regrowth,
orhair loss will begin again.

Other information

STORAGE AND HANDLING SECTION

Before use, read all information on carton.
Keep the carton. It contains important information.
Store at 20-25°C(68-77°F).
Keep tightly closed.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Minoxidil, Propylene Glycol,
DimethylIsosorbide,Aqua, Biotin,
Panthenol, Niacinamide

Package Label - Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

undefinedundefined

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87793-00187793-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YABERCHA HAIR GROWTH SERUMYABERCHA HAIR GROWTH SERUMYiwu Blackeye Import and Export Co Ltd.547dc747-3104-c433-e063-6394a90a0c7c2026-06-17WarningsExact identifier
ndc (package): 87793-001-01
ndc (product): 87793-001
ndc11 (package): 87793000101
spl id: 547dd484-a44c-4c53-e063-6294a90a843d
spl set id: 547dc747-3104-c433-e063-6394a90a0c7c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.